How can innovation be harnessed in the healthcare sector? In this panel discussion, professionals discuss new products and ventures they've been involved in to impact the biotechnology field. Topics range from laser film recorders to support tools for companies that break down barriers, to improving social health. The discussion was part of the 2011 Healthcare Summit, held at the Stanford Graduate School of Business.
Dr. Moira Gunn talks about new diagnostics and therapy for autism with Seaside Therapeutics CEO, Randall Carpenter.
Dr. Moira Gunn learns about a new treatment for macular degeneration using stem cells from Advanced Cell Technology CEO, Gary Rabin.
Dr. Moira Gunn talks about the new book, Rabid: A Cultural History of the World's Most Diabolical Virus, with co-authors Bill Wasik and Monica Murphy.
Dr. Moira Gunn looks at Medical Diagnostics, from brain scans for Alzheimer's to other neurological conditions with Positron Emission Tomography General Manager, Jonathan Allis.
Dr. Moira Gunn sits down with Dusa Pharmaceuticals President and CEO, Bob Doman to talk about a new treatment for sunspots, a common term for pre-cancerous skin lesions.
Dr. Moira Gunn sits down with Martin McGlynn, President and CEO of Stem Cells Inc. to talk about how stem cells are being used to treat everything from spinal cord injury and age-related macular degeneration.
Dr. Moira Gunn talks about the process behind engineering new vaccines by typing DNA sequences into a computer with Inovio Pharmaceuticals CEO, Joseph Kim.
Dr. Moira Gunn chats with John Latham, Chief Scientific Officer for Alder Biopharmaceuticals, about how they are winning the fight against migraines.
Dr. Moira Gunn talks about new vaccines for neglected diseases and about a handheld device which can detect disease on the spot with the CEOs from Inviragen and Opko Diagnostics, Dan Stinchcomb and David Steinmiller.